...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of breast imaging. >Image-guided Procedure Versus 2-year Follow-up for a BI-RADS 3 Probably Benign Lesion: A Cost Comparison Analysis
【24h】

Image-guided Procedure Versus 2-year Follow-up for a BI-RADS 3 Probably Benign Lesion: A Cost Comparison Analysis

机译：图像引导手术和2年随访BI-RADS 3可能良性病变:成本比较分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: Perform a comparison between the costs of image-guided breast procedures versus 2-year imaging follow-up for findings classified as BI-RADS assessment category 3-probably benign. Methods: The national payment amount costs at non-facility locations were obtained from the Centers for Medicare and Medicaid Services physician fee schedule for breast imaging-related Current ProceduralTerminology codes.Total costs were calculated and compared for management algorithms of 2-year imaging follow-up of a BI-RADS 3 lesion from 2018 through 2019 versus performing an image-guided procedure of the lesion in 2018 after the initial diagnostic imaging. Results: Two-year mammographic follow-up of a BI-RADS 3 finding costs $484.This was less than a stereotactic-guided breast biopsy, which cost at least $1055. Two-year follow-up for a probably benign US finding cost $615 compared to $1173 for the least expensive US-guided breast biopsy scenario. For breast MRI, 2-year imaging follow-up cost $1510, which was also less than most MRI-guided breast biopsy scenarios.The one exception in which biopsy costs less than 2-year imaging follow-up was in the setting of an MRI-guided biopsy in the average-risk population without a post-benign biopsy follow-up breast MRI; in this setting, MRI biopsy cost $1235. Conclusion: In 2018-2019, 2-year imaging follow-up of a BI-RADS 3 finding continues to be less costly than an immediate procedure, except for MRI-guided breast biopsy in the average-risk population without a post-benign biopsy follow-up MRI.
机译：摘要目的:执行成本之间的比较图像引导乳房程序和2年影像学随访结果分为BI-RADS评估类别3-probably良性的。方法:国家支付成本non-facility位置获得的医疗保险和医疗补助服务中心乳房imaging-related的医生费用表当前ProceduralTerminology代码。计算和比较了管理2年成像跟踪的算法从2018年到2019年与BI-RADS 3病变执行图像引导的过程病变在2018年最初的诊断成像。BI-RADS 3发现成本484美元。比stereotactic-guided乳房活检,花费至少1055美元。可能良性相比,我们发现成本615美元1173美元最便宜US-guided乳房活检的场景。后续成本1510美元,还不到大多数mri引导下的乳房活检场景。异常的检查成本不到2年成像跟踪的设置mri引导下活检的人口平均风险没有post-benign乳房活组织检查随访核磁共振;结论:在2018 - 2019年,2年成像后续的BI-RADS 3找到继续低成本比立即手术,除了mri引导下的乳房活检的平均风险人口没有post-benign活组织检查随访核磁共振。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号